| 4R-CHOP+2R current study | 6R-CHOP NCT 00854568159 | P value |
---|---|---|---|
Characteristic | No. (%) | No. (%) | Â |
No. of patients | 63 | 128 | Â |
Age, year | Â | Â | Â |
Median (range) | 47.9 (18–74) | 49.3 (18–77) |  |
≤60y | 51 (81) | 113 (88.3) | 0.25 |
>60y | 12 (19) | 15 (11.7) | Â |
Gender | Â | Â | Â |
Male | 36 (57.1) | 72 (56.2) | 0.97 |
Female | 27 (42.9) | 56 (43.8) | Â |
Ann Arbor Stage | Â | Â | Â |
I | 27 (42.9) | 63 (49.2) | 0.50 |
II | 36 (57.1) | 65 (50.8) | Â |
ECOG PS | Â | Â | Â |
0 | 40 (63.5) | 82 (64) | 0.93 |
1 | 23 (36.5) | 46 (36) | Â |
B symptoms | Â | Â | Â |
No | 61 (96.8) | 119 (93) | 0.46 |
Yes | 2 (3.2) | 9 (7) | Â |
LDH level | Â | Â | Â |
Normal | 60 (95.2) | 120 (93.8) | 0.93 |
Elevated | 3 (4.8) | 8 (6.3) | Â |
IPI score | Â | Â | Â |
0 | 51 (81) | 106 (82.8) | 0.13 |
1 | 10 (15.9) | 22 (17.2) | Â |
2 | 2(3.2) | 0 (0) | Â |